Hep c vaccine from.....Cuba?, page-9

My issue, with BLT, is not what the technology has the potential to deliver, it's somewhat the targets they picked and also, it's a time thing, given it's a brand new technology, the fact such technology was allowed to sit, for years, in limbo by regulators and others, is a scandal IMO.

Again, targeting things like, hypertension and T2D would put this thing into really game changing space! [particularly hypertension - T2D already got some game changers starting to appear ie, MSB in Oz and Xbiotech in the US and others].

Calimmune is fascinating and very welcome in the HIV/AIDS space, but the Hep space? hmmm. But then again, they too can "prove" the technology.

Just an end of the work day rant. Now...back to reality....